Paraplatin Side Effects

Generic name: carboplatin

Medically reviewed by Philip Thornton, DipPharm. Last updated on Jun 8, 2023.

Note: This document contains side effect information about carboplatin. Some dosage forms listed on this page may not apply to the brand name Paraplatin.

Applies to carboplatin: intravenous powder for solution, intravenous solution.

Serious side effects of Paraplatin

Along with its needed effects, carboplatin (the active ingredient contained in Paraplatin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.

Check with your doctor as soon as possible if any of the following side effects occur while taking carboplatin:

More common

• Pain at place of injection

Less common

• Black, tarry stools
• blood in urine or stools
• cough or hoarseness, accompanied by fever or chills
• fever or chills
• lower back or side pain, accompanied by fever or chills
• numbness or tingling in fingers or toes
• painful or difficult urination, accompanied by fever or chills
• pinpoint red spots on skin
• skin rash or itching
• unusual bleeding or bruising
• unusual tiredness or weakness

Rare

• Blurred vision
• ringing in ears
• sores in mouth and on lips
• wheezing

Other side effects of Paraplatin

Some side effects of carboplatin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Nausea and vomiting
• unusual tiredness or weakness

Less common

• Constipation or diarrhea
• loss of appetite

This medicine may cause a temporary loss of hair in some people. After treatment with carboplatin has ended, normal hair growth should return.

For Healthcare Professionals

Applies to carboplatin: intravenous powder for injection, intravenous solution.

Hematologic

Very common (10% or more): Leukopenia (98%), neutropenia (97%), anemia (91%), thrombocytopenia (70%), bleeding (10%)

Rare (less than 0.1%): Febrile neutropenia

Frequency not reported: Bone marrow failure, hemolytic-uremic syndrome^[Ref]

Gastrointestinal

Very common (10% or more): Nausea (93%), vomiting (84%), adverse GI effects (50%), abdominal pain

Common (1% to 10%): Mucositis, diarrhea, constipation

Frequency not reported: Stomatitis, pancreatitis^[Ref]

Nervous system

Very common (10% or more): Central neurotoxicity (26%), peripheral neuropathy (15%)

Common (1% to 10%): Other sensory side effects, paresthesia, decrease of osteotendinous reflexes, sensory disturbance, dysgeusia

Frequency not reported: Cerebrovascular accident, reversible posterior leukoencephalopathy syndrome (RPLS)^[Ref]

Hepatic

Very common (10% or more): Alkaline phosphatase elevations (29%), SGOT elevations (20%), aspartate aminotransferase increased, liver function test abnormal

Common (1% to 10%): Bilirubin elevations^[Ref]

Renal

Very common (10% or more): Blood urea elevations (17%), creatinine renal clearance decreased^[Ref]

Other

Very common (10% or more): Pain (44%), asthenia (41%), ototoxicity (12%)

Common (1% to 10%): Asthenia

Frequency not reported: Malaise^[Ref]

Hypersensitivity

Common (1% to 10%): Hypersensitivity, anaphylactoid type reaction^[Ref]

Metabolic

Very common (10% or more): Magnesium loss (61%), potassium loss (16%), calcium loss (16%), sodium loss (10%)

Rare (less than 0.1%): Hyponatremia

Frequency not reported: Dehydration, anorexia, tumor lysis syndrome^[Ref]

Ocular

Rare (less than 0.1%): Visual disturbance (including rare cases of loss of vision)^[Ref]

Immunologic

Very common (10% or more): Infection (14%)

Local

Frequency not reported: Injection site necrosis, injection site reaction, injection site extravasation, injection site erythema

Musculoskeletal

Common (1% to 10%): Musculoskeletal disorder^[Ref]

Genitourinary

Common (1% to 10%): Urogenital disorder^[Ref]

Oncologic

Frequency not reported: Neoplasms (e.g., benign, malignant, unspecified) including cysts and polyps^[Ref]

Respiratory

Common (1% to 10%): Respiratory disorder, interstitial lung disease, bronchospasm

Frequency not reported: Pneumonia^[Ref]

Cardiovascular

Common (1% to 10%): Cardiovascular disorder

Frequency not reported: Cardiac failure, embolism, hypertension, hypotension^[Ref]

Dermatologic

Very common (10% or more): Alopecia (49%), skin disorder

Frequency not reported: Urticaria, rash, erythema, pruritus^[Ref]

Frequently asked questions

• Why give Taxol (Paxel) before carboplatin?
• How does carboplatin stop cancer?
• Does carboplatin cause neuropathy?

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer